Join
Live feed
·
INSIDERFilingvia Quantisnow
Aldeyra Therapeutics Inc. logo

President and CEO Brady Todd C bought $418,450 worth of shares (250,000 units at $1.67), increasing direct ownership by 17% to 1,721,298 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ALDX· Aldeyra Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALDX (Aldeyra Therapeutics Inc.) and more on Quantisnow.